Mar 24, 2021 7:00am EDT Second Sight Medical Products Announces $27.9 Million Private Placement of Common Stock
Mar 05, 2021 8:00am EST Second Sight Medical Products, Inc. Receives FDA Approval for the Argus 2s Retinal Prosthesis System
Sep 22, 2020 8:00am EDT Second Sight Medical Products Inc. Announces Resumption of Its Early Feasibility Study of the Orion® Cortical Visual Prosthesis at UCLA
May 05, 2020 1:08pm EDT Second Sight Medical Products Inc. Announces Closing of Public Offering of Common Stock
Apr 30, 2020 8:43pm EDT Second Sight Medical Products Announces Pricing of Public Offering of Common Stock
Mar 30, 2020 1:15pm EDT Second Sight Announces Employee Layoffs, Intent to Wind Down Operations and Appointment of Matthew Pfeffer as Acting CEO
Mar 16, 2020 8:00am EDT Second Sight to Discuss Fourth Quarter and Year-End 2019 Financial Results on March 19, 2020 Conference Call
Mar 12, 2020 4:15pm EDT Second Sight Announces Departure of Will McGuire, President and CEO, and Appointment of Gregg Williams as Acting CEO